Dr Klaus Hellmann
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Dr Klaus Hellmann
Klifovet recently held a conference on the expectations of the Annex 2 proposal of Regulation 2019/6 in Munich, where a host of stakeholders from the European Medicines Agency, national regulatory agencies and the animal health industry attended. The contract research organization's chief executive Dr Klaus Hellman provided Animal Pharm with an overview of the pertinent topics covered.
With the UK awaiting a hard or soft Brexit, many aspects of its EU divorce are still unknown. Klifovet is attempting to provide its clients with some regulatory clarity once Brexit is finalized. Dr Klaus Hellman gave Animal Pharm his point of view.
Dr Klaus Hellman, the chief executive of Klifovet, gives Animal Pharm an insight into the science and statistics behind clinical endpoints. This exclusive insight explains why is this data so crucial to the animal health sector.